Literature DB >> 9604148

Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats.

A A Bertelli1, L Giovannini, R Stradi, S Urien, J P Tillement, A Bertelli.   

Abstract

In view of the increasing interest in the biological activity of resveratrol, one of the components of red wine which is considered to be one of the main ingredients responsible for the beneficial effect of wine on human health, we have studied plasma kinetics and tissue bioavailability of this compound after red wine oral administration in rats. Plasma pharmacokinetics after oral administration of resveratrol could be described by an open one- or two-compartment model. Tissue concentrations show a significant cardiac bioavailability, and a strong affinity for the liver and kidneys.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9604148

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  10 in total

Review 1.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Resveratrol-induced gene expression profiles in human prostate cancer cells.

Authors:  Sunita B Jones; Samuel E DePrimo; Michael L Whitfield; James D Brooks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

Review 3.  Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen.

Authors:  Nazar Labinskyy; Anna Csiszar; Gabor Veress; Gyorgyi Stef; Pal Pacher; Gabor Oroszi; Joseph Wu; Zoltan Ungvari
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

4.  Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy.

Authors:  Tzu-Hurng Cheng; Ju-Chi Liu; Heng Lin; Neng-Lang Shih; Yen-Ling Chen; Meng-Ting Huang; Paul Chan; Ching-Feng Cheng; Jin-Jer Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-09       Impact factor: 3.000

5.  Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes.

Authors:  Feng-Cheng Liu; Li-Feng Hung; Wan-Lin Wu; Deh-Ming Chang; Chuan-Yueh Huang; Jenn-Haung Lai; Ling-Jun Ho
Journal:  Arthritis Res Ther       Date:  2010-09-08       Impact factor: 5.156

6.  The effects of resveratrol on cyclooxygenase-1 and cyclooxygenase-2 mRNA and protein levels in diabetic rat kidneys.

Authors:  Atiye Seda Yar; Sevda Menevse; Ebru Alp; Fatma Helvacioglu; Gulnur Take
Journal:  Mol Biol Rep       Date:  2009-08-20       Impact factor: 2.316

7.  Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.

Authors:  Esra Mutlu; Seth T Gibbs; Natalie South; Jessica Pierfelice; Brian Burback; Dori Germolec; Suramya Waidyanatha
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-20       Impact factor: 4.219

8.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

9.  Resveratrol increases nitric oxide production in the rat thick ascending limb via Ca2+/calmodulin.

Authors:  Agustin Gonzalez-Vicente; Pablo D Cabral; Jeffrey L Garvin
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

10.  Repressive effects of resveratrol on androgen receptor transcriptional activity.

Authors:  Wen-feng Shi; Melanie Leong; Ellen Cho; Joseph Farrell; Han-chun Chen; Jun Tian; Dianzheng Zhang
Journal:  PLoS One       Date:  2009-10-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.